The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Thomson, A. W. (1994) · Cited by 1,116
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Navarro-González, J. F., & Mora-Fernández, C. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091048 · Cited by 932
Self-citationTumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.
Laster, S. M., Wood, J. G., & Gooding, L. R. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.8.2629 · Cited by 903
How Does Proteinuria Cause Progressive Renal Damage?
Abbate, M., Zoja, C., & Remuzzi, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040377 · Cited by 779
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
RANTES: a versatile and controversial chemokine
Appay, V., & Rowland-Jones, S. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01812-3 · Cited by 650
Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00367.x · Cited by 551
Han, J., Thompson, P., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.391 · Cited by 508
Transcription factor-κB (NF-κB) and renal disease
Guijarro, C., & Egido, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002415.x · Cited by 479
Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure
Melnikov, V. Y., Ecder, T., Fantuzzi, G., Siegmund, B., Lucia, M. S., Dinarello, C. A., Schrier, R. W., & Edelstein, C. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12089 · Cited by 476
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J., & Tesch, G. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000014 · Cited by 440
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
Wójciak-Stothard, B., Entwistle, A., Garg, R., & Ridley, A. J. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<150::aid-jcp17>3.0.co;2-b · Cited by 394
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
Coimbra, T. M., Janssen, U., Gröne, H. J., Ostendorf, T., Kunter, U., Schmidt, H., Brabant, G., & Floege, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00836.x · Cited by 377
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
Galkina, E., & Ley, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080859 · Cited by 376
Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy
Cooper, M. E. (2001) · Diabetologia · doi:10.1007/s001250100000 · Cited by 375
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
Melnikov, V. Y., Faubel, S. G., Siegmund, B., Lucia, M. S., Ljubanović, D. G., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15623 · Cited by 341
Wada, T., Furuichi, K., Sakai, N., Iwata, Y., Yoshimoto, K., Shimizu, M., Takeda, S.-I., Takasawa, K., Yoshimura, M., Kida, H., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00311.x · Cited by 341
Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney
Kitagawa, K., Wada, T., Furuichi, K., Hashimoto, H., Ishiwata, Y., Asano, M., Takeya, M., Kuziel, W. A., Matsushima, K., Mukaida, N., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63292-0 · Cited by 330
Yerneni, K. K., Bai, W., Khan, B. V., Medford, R. M., & Natarajan, R. (1999) · Diabetes · doi:10.2337/diabetes.48.4.855 · Cited by 328
Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.
Sassy-Prigent, C., Heudes, D., Mandet, C., Bélair, M. F., Michel, O., Perdereau, B., Bariéty, J., & Bruneval, P. (2000) · Diabetes · doi:10.2337/diabetes.49.3.466 · Cited by 328
Fractalkine in Vascular Biology: From Basic Research to Clinical Disease
Umehara, H., Bloom, E. T., Okazaki, T., Nagano, Y., Yoshie, O., & Imai, T. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000095360.62479.1f · Cited by 319
Melnikov, V. Y., Faubel, S., Siegmund, B., Lucia, M. S., Ljubanovic, D., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215623 · Cited by 316
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.039 · Cited by 309
mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats
Nakamura, T., Fukui, M., Ebihara, I., Osada, S., Nagaoka, I., Tomino, Y., & Koide, H. (1993) · Diabetes · doi:10.2337/diab.42.3.450 · Cited by 307
Pentoxifylline suppression of tumor necrosis factor gene transcription.
Doherty, G. M., Jensen, J. C., Alexander, H. R., Buresh, C. M., & Norton, J. A. (1991) · PubMed · Cited by 306
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Dalla Vestra, M., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 303
Okada, S., Shikata, K., Matsuda, M., Ogawa, D., Usui, H., Kido, Y., Nagase, R., Wada, J., Shikata, Y., & Makino, H. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2586 · Cited by 298
Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270
Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy
Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., & Kondo, M. (1991) · Kidney International · doi:10.1038/ki.1991.308 · Cited by 268
Chow, F. Y., Nikolic-Paterson, D. J., Ma, F. Y., Ozols, E., Rollins, B. J., & Tesch, G. H. (2007) · Diabetologia · doi:10.1007/s00125-006-0497-8 · Cited by 250
Tumor necrosis factor induces glomerular damage in the rabbit.
Bertani, T., Abbate, M., Zoja, C., Corna, D., Perico, N., Ghezzi, P., & Remuzzi, G. (1989) · Europe PMC (PubMed Central) · Cited by 246
Navarro, J. F., Mora, C., Macıéa, M., & Garcıéa, J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00408-6 · Cited by 238
Thomson, S. C., Deng, A., Bao, D., Satriano, J., Blantz, R. C., & Vallon, V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10963 · Cited by 236
Sucosky, P., Balachandran, K., Elhammali, A., Jo, H., & Yoganathan, A. P. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.176347 · Cited by 235
McCarthy, E. T., Sharma, R., Sharma, M., Li, J. Z., Ge, X. L., Dileepan, K. N., & Savin, V. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93433 · Cited by 231
Role of inflammation in diabetic complications
Navarro, J. F., & Mora, C. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi155 · Cited by 227
Navarro, J. F., Milena, F. J., Mora, C., León, C., & García, J. (2006) · American Journal of Nephrology · doi:10.1159/000098004 · Cited by 220
Nakamura, A., Shikata, K., Hiramatsu, M., Nakatou, T., Kitamura, T., Wada, J., Itoshima, T., & Makino, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2890 · Cited by 218
A Transmembrane Tight Junction Protein Selectively Expressed on Endothelial Cells and Platelets
Nasdala, I., Wolburg-Buchholz, K., Wolburg, H., Kuhn, A., Ebnet, K., Brachtendorf, G., Samulowitz, U., Kuster, B., Engelhardt, B., Vestweber, D., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111999200 · Cited by 216
Ohga, S., Shikata, K., Yozai, K., Okada, S., Ogawa, D., Usui, H., Wada, J., Shikata, Y., & Makino, H. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00288.2005 · Cited by 203
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini, R., Velussi, M., Brocco, E., Bruseghin, M., Abaterusso, C., Saller, A., Dalla Vestra, M., Carraro, A., Bortoloso, E., Sambataro, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.3.476 · Cited by 202
Pieper, G. M., & Riaz-ul-Haq (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199710000-00019 · Cited by 198
Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
Utimura, R., Fujihara, C. K., Mattar, A. L., Malheiros, D. M. A. C., de Lourdes Noronha, I., & Zatz, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00736.x · Cited by 196
Pfeilschifter, J., Pignat, W., Vosbeck, K., & Märki, F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90003-x · Cited by 191
Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability
Royall, J. A., Berkow, R. L., Beckman, J. S., Cunningham, M. K., Matalon, S., & Freeman, B. A. (1989) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1989.257.6.l399 · Cited by 182
ACE Inhibitors Improve Diabetic Nephropathy Through Suppression of Renal MCP-1
Amann, B., Tinzmann, R., & Angelkort, B. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2421 · Cited by 179
Why is proteinuria an ominous biomarker of progressive kidney disease?
Zandi-Nejad, K., Eddy, A. A., Glassock, R. J., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09220.x · Cited by 178
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy
Morii, T., Fujita, H., Narita, T., Shimotomai, T., Fujishima, H., Yoshioka, N., Imai, H., Kakei, M., & Ito, S. (2003) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00176-9 · Cited by 177
In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy
Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y., & Sakai, H. (1995) · Diabetes · doi:10.2337/diab.44.10.1233 · Cited by 175
Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis
Wada, T., Furuichi, K., Sakai, N., Iwata, Y., Kitagawa, K., Ishida, Y., Kondo, T., Hashimoto, H., Ishiwata, Y., Mukaida, N., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000120371.09769.80 · Cited by 172
Han, S.-Y., Kim, C.-H., Kim, H.-S., Jee, Y.-H., Song, H.-K., Lee, M.-H., Han, K.-H., Kim, H.-K., Kang, Y.-S., Han, J.-Y., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111196 · Cited by 172
Prevention of End-Stage Renal Disease Due to Type 2 Diabetes
Hostetter, T. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451209 · Cited by 169
Kalantarinia, K., Awad, A. S., & Siragy, H. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00237.x · Cited by 156
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
DiPetrillo, K., Coutermarsh, B., & Gesek, F. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00026.2002 · Cited by 154
Choi, J.-S., Choi, Y. J., Park, S.-H., Kang, J.-S., & Kang, Y. (2004) · Journal of Nutrition · doi:10.1093/jn/134.5.1013 · Cited by 154
Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., & Makino, H. (1999) · Diabetologia · doi:10.1007/s001250051241 · Cited by 152
Lee, F., Cao, Z., Long, D. M., Panagiotopoulos, S., Jerums, G., Cooper, M. E., & Forbes, J. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135055.61833.a8 · Cited by 150
Navarro‐González, J. F., Milena, F. F., Mora, C., León, C., Claveríe‐Martín, F., Flores, C. G., & Garcı́a, J. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09918.x · Cited by 145
Self-citationNavarro‐González, J. F., Fernández, C. M., Rivero, A., Gallego, E., Chahin, J., Macia, M. L., Méndez, M. L., & García, J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70182-4 · Cited by 143
Self-citationROLE OF MACROPHAGES IN COMPLICATIONS OF TYPE 2 DIABETES
Tesch, G. H. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04729.x · Cited by 142
Tashiro, K., Koyanagi, I., Saitoh, A., Shimizu, A., Shike, T., Ishiguro, C., Koizumi, M., Funabïki, K., Horikoshi, S., Shirato, I., et al. (2002) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.2057 · Cited by 141
Niewczas, M. A., Ficociello, L., Johnson, A. C., Walker, W., Rosolowsky, E. T., Roshan, B., Warram, J. H., & Królewski, A. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03010608 · Cited by 139
Lee, E. Y., Chung, C. H., Khoury, C. C., Yeo, T. K., Pyagay, P. E., Wang, A., & Chen, S. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90642.2008 · Cited by 135
Ko, G.-J., Kang, Y. S., Han, S. Y., Lee, M. H., Song, H. K., Han, K. H., Kim, H. K., Han, J., & Cha, D. R. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn157 · Cited by 132
α-Actinin-4 Is Required for Normal Podocyte Adhesion
Dandapani, S. V., Sugimoto, H., Matthews, B. D., Kolb, R. J., Sinha, S., Gerszten, R. E., Zhou, J., Ingber, D. E., Kalluri, R., & Pollak, M. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605024200 · Cited by 131
Donadelli, R., Zanchi, C., Morigi, M., Buelli, S., Batani, C., Tomasoni, S., Corna, D., Rottoli, D., Benigni, A., Abbate, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000089564.55411.7f · Cited by 131
Elder, M. (1997) · KARGER eBooks · doi:10.1159/000060714 · Cited by 126
The Role of chemokines and chemokine receptors in diabetic nephropathy
Rüster, C. (2007) · Frontiers in bioscience · doi:10.2741/2734 · Cited by 126
Navarro‐González, J. F., Fernández, C. M., Muros, M., & García, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl469 · Cited by 122
Self-citationNavarro‐González, J. F., Mora, C., Muros, M., & Garcı́a, J. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010001 · Cited by 121
Self-citationTarabra, E., Giunti, S., Barutta, F., Salvidio, G., Burt, D. J., Deferrari, G., Gambino, R., Vergola, D., Pinach, S., Perin, P. C., et al. (2009) · Diabetes · doi:10.2337/db08-0895 · Cited by 120
Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes
Herder, C., Peltonen, M., Köenig, W., Kräft, I., Müller-Scholze, S., Martin, S., Lakka, T. A., Ilanne‐Parikka, P., Eriksson, J. G., Hämäläinen, H., et al. (2006) · Diabetes · doi:10.2337/db05-1320 · Cited by 120
Wong, C. K., Ho, A. M. ‐., Tong, P. C. Y., Yeung, C. Y., Kong, A. P. S., Lun, S. W., Chan, J. C. N., & Lam, C. W. K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03389.x · Cited by 116
The Effect of Pentoxifylline on Proteinuria in Diabetic Kidney Disease: A Meta-analysis
McCormick, B. B., Sydor, A., Akbari, A., Fergusson, D. A., Doucette, S. P., & Knoll, G. A. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.025 · Cited by 115
Interleukin-6: An autocrine regulator of mesangial cell growth
COLEMAN, D. L., & Ruef, C. (1992) · Kidney International · doi:10.1038/ki.1992.91 · Cited by 114
Increased expression of selectins in kidneys of patients with diabetic nephropathy
Hirata, K., Shikata, K., Matsuda, M., Akiyama, K., Sugimoto, H., Kushiro, M., & Makino, H. (1998) · Diabetologia · doi:10.1007/s001250050888 · Cited by 114
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Moriwaki, Y., Inokuchi, T., Yamamoto, A., Ka, T., Tsutsumi, Z., Takahashi, S., & Yamamoto, T. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0007-6 · Cited by 110
Mysore, T. B., Shinkel, T. A., Collins, J., Salvaris, E. J., Fisicaro, N., Murray-Segal, L. J., Johnson, L. E. A., Lepore, D. A., Walters, S. N., Stokes, R., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2109 · Cited by 110
The MIF Receptor CD74 in Diabetic Podocyte Injury
Sánchez-Niño, M. D., Sanz, A. B., Ihalmo, P., Lassila, M., Holthöfer, H., Mezzano, S. A., Aros, C., Groop, P., Saleem, M. A., Mathieson, P. W., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020194 · Cited by 110
Expression of the fractalkine receptor (CX3CR1) in human kidney diseases
Segerer, S., Hughes, E., Hudkins, K. L., Mack, M., Goodpaster, T. A., & Alpers, C. E. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00480.x · Cited by 109
The Death Ligand TRAIL in Diabetic Nephropathy
Lorz, C., Benito‐Martín, A., Boucherot, A., Ucero, A. C., Rastaldi, M. P., Henger, A., Armelloni, S., Accent]a, B. S. A., Berthier, C. C., Kretzler, M., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050581 · Cited by 106
Baud, L., Perez, J., Friedlander, G., & Ardaillou, R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80543-x · Cited by 105
Jones, S. G., Jones, S., & Phillips, A. O. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051739.x · Cited by 104
Koike, N., Takamura, T., & Kaneko, S. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.001 · Cited by 103
Lopes-Virella, M. F., Carter, R. E., Gilbert, G. E., Klein, R. L., Jaffa, M. A., Jenkins, A. J., Lyons, T. J., Garvey, W. T., Virella, G., & and the DCCT/EDIC Cohort Study Group (2008) · Diabetes Care · doi:10.2337/dc08-0659 · Cited by 101
Lin, J., Glynn, R. J., Rifai, N., Manson, J. E., Ridker, P. M., Nathan, D. M., & Schaumberg, D. A. (2008) · Diabetes Care · doi:10.2337/dc08-0277 · Cited by 98
Cooper, A. C., Mikhail, A. I., Lethbridge, M. W., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000131523.17045.56 · Cited by 95
Gruden, G., Setti, G., Hayward, A. E., Sugden, D., Duggan, S., Burt, D. J., Buckingham, R. E., Gnudi, L., & Viberti, G. C. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004030251 · Cited by 90
Furuichi, K., Wada, T., Sakai, N., Iwata, Y., Yoshimoto, K., Shimizu, M., Kobayashi, K., Takasawa, K., Kida, H., Takeda, S.-I., et al. (2000) · American Journal of Nephrology · doi:10.1159/000013603 · Cited by 89
Dai, S., Matsuno, H., Nakamura, H., Nishioka, K., & Yudoh, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20064 · Cited by 89
Miyauchi, K., Takiyama, Y., Honjo, J., Tateno, M., & Haneda, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.018 · Cited by 88
DiPetrillo, K., & Gesek, F. A. (2004) · American Journal of Nephrology · doi:10.1159/000079121 · Cited by 87
Soedamah‐Muthu, S. S., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D. A., Ebeling, P., & Fuller, J. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.06.005 · Cited by 82
Detection of Serum IL-6 in Patients with Diabetic Nephropathy
Sekizuka, K., Tomino, Y., Sei, C., et al. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188281 · Cited by 81
Araki, S., Haneda, M., Koya, D., Sugimoto, T., Isshiki, K., Chin‒Kanasaki, M., Uzu, T., & Kashiwagi, A. (2007) · Diabetologia · doi:10.1007/s00125-006-0586-8 · Cited by 81
Martini, S., Eichinger, F. H., Nair, V., & Kretzler, M. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9103-3 · Cited by 76
Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)
Mariño, E., & Cardier, J. E. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00150-9 · Cited by 70
Ortíz, A., Bustos, C., Alonso, J., Alcázar, R., López-Armada, M. J., Plaza, J. J. G., González, E. M., & Egido, J. (1995) · PubMed · Cited by 70
Fujita, T., Ogihara, N., Kamura, Y., Satomura, A., Fuke, Y., Shimizu, C., Wada, Y., & Matsumoto, K. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0178-4 · Cited by 66
Sumagin, R., & Sarelius, I. H. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00248.2006 · Cited by 66
Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
Guerrero‐Romero, F., Rodríguez‐Morán, M., Paniagua-Sierra, J. R., García-Bulnes, G., Salas-Ramírez, M., & Amato, D. (1995) · PubMed · Cited by 65
Stuyt, R. J. L., Netea, M. G., Geijtenbeek, T. B. H., Kullberg, B. J., Dinarello, C. A., & van der Meer, J. W. M. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01747.x · Cited by 64
Proteinuria and Activated T-Lymphocytes in Diabetic Nephropathy
Bending, J. J., Lobo-Yeo, A., Vergani, D., & Viberti, G. C. (1988) · Diabetes · doi:10.2337/diab.37.5.507 · Cited by 63
Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes
Lin, J., Hu, F. B., Mantzoros, C. S., & Curhan, G. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1597-z · Cited by 63
Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat
Rodríguez‐Iturbe, B., Quiroz, Y., Shahkarami, A., Li, Z., & Vaziri, N. D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00496.x · Cited by 63
Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats
Voisin, L., Breuillé, D., Ruot, B., Rallière, C., Rambourdin, F., Dalle, M., & Obled, C. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.5.r1412 · Cited by 61
Regulation of renal transport processes and hemodynamics by macrophages and lymphocytes
Schreiner, G. F., & Kohan, D. E. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.4.f761 · Cited by 58
Kidney Diseases and Chemokines
Panzer, U., Steinmetz, O. M., Stahl, R. A. K., & Wolf, G. (2006) · Current Drug Targets · doi:10.2174/138945006775270213 · Cited by 57
Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys
Kikuchi, Y., Ikee, R., Hemmi, N., Hyodo, N., Saigusa, T., Namikoshi, T., Yamada, M., Suzuki, S., & Miura, S. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077594 · Cited by 56
Navarro‐González, J. F., Muros, M., Fernández, C. M., Herrera, H., Meneses, B., & Garcı́a, J. G. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.09.003 · Cited by 56
Self-citationRole of Macrophages in the Pathogenesis of Diabetic Nephropathy
Shikata, K., & Makino, H. (2001) · KARGER eBooks · doi:10.1159/000060147 · Cited by 53
Rodríguez‐Morán, M., González-González, G. M., Bermúdez-Barba, M. V., Garza, C., Tamez-Pérez, H. E., Martínez-Martínez, F. J., & Guerrero‐Romero, F. (2006) · Clinical Nephrology · doi:10.5414/cnp66003 · Cited by 45
Mizuno, M., Sada, T., Kato, M., Fukushima, Y., Terashima, H., & Koike, H. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000245241.79959.d6 · Cited by 40
Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy
Hara, T., Ishida, T., Cangara, H. M., & Hirata, K. (2009) · Microvascular Research · doi:10.1016/j.mvr.2009.01.002 · Cited by 39
Vascular cell adhesion molecule-l expression in the renal interstitium of diabetic KKAy mice
Ina, K., Kitamura, H., Okeda, T., Nagai, K., Liu, Z. Y., Matsuda, M., & Fujikura, Y. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00011-x · Cited by 39
Roozbeh, J., Banihashemi, M. A., Ghezlou, M., Afshariani, R., Salari, S., Moini, M., & Sagheb, M. M. (2010) · Renal Failure · doi:10.3109/08860221003602645 · Cited by 37
Reduction of Macroalbuminuria With Pentoxifylline in Diabetic Nephropathy: Report of three cases
Gorson, D. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2190b · Cited by 36
Iwamoto, M., Mizuiri, S., Arita, M., & Hemmi, H. (2005) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.206.163 · Cited by 35
Vilček, J. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50005-3 · Cited by 33
The next generation of diabetic nephropathy therapies: An update
Williams, M. E., & Tuttle, K. R. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.011 · Cited by 30
Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats
Janiak, P., Bidouard, J., Cadrouvele, C., Poirier, B., Gouraud, L., Grataloup, Y., Pierre, F., Bruneval, P., O'Connor, S. E., & Herbert, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.032 · Cited by 29
Extracellular signals and intracellular pathways in diabetic nephropathy
Chuang, L., & Guh, J. (2001) · Nephrology · doi:10.1046/j.1440-1797.2001.00043.x · Cited by 28
Pfeilschifter, J., & Mühl, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90371-s · Cited by 26
Expression of Alpha-actinin-4 in Human Diabetic Nephropathy
Kimura, M., Toyoda, M., Kato, M., Kobayashi, K., Abe, M., Kobayashi, T., Miyauchi, M., Yamamoto, N., Umezono, T., & Suzuki, D. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0352 · Cited by 20
Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli
Kikuchi, Y., Imakiire, T., Hyodo, T., Kushiyama, T., Higashi, K., Hyodo, N., Suzuki, S., & Miura, S. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi232 · Cited by 19
Efecto de la pentoxifilina sobre la evolución de la nefropatía diabética
Leyva-Jiménez, R., Rodríguez-Orozco, A. R., Ortega-Pierres, L. E., Ramírez-Enríquez, J., Gómez‐García, A., & Álvarez-Aguilar, C. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.05.024 · Cited by 18
[Effect of trental on indices kidney function in diabetes mellitus].
Blagosklonnaia, I. V., Mamedov, R., Kozlov, V. V., Emanuel, V. L., & Kudriashova, M. I. (1982) · PubMed · Cited by 17
Tissue-Specific Induction of E-Selectin in Glomeruli Is Augmented following Diabetes mellitus
Narumi, S., Onozato, M. L., Tojo, A., Sakamoto, S., & Tamatani, T. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000046063 · Cited by 15
Cited by
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment
Samsu, N. (2021) · BioMed Research International · doi:10.1155/2021/1497449 · Cited by 1,001
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Cowie, M. R., & Fisher, M. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0406-8 · Cited by 784
Ruiz, S., Pergola, P. E., Zager, R. A., & Vaziri, N. D. (2013) · Kidney International · doi:10.1038/ki.2012.439 · Cited by 718
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Jun, J.-I., & Lau, L. F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3599 · Cited by 568
The impact of diabetes on periodontal diseases
Graves, D. T., Ding, Z., & Yang, Y. (2020) · Periodontology 2000 · doi:10.1111/prd.12318 · Cited by 398
Metadata
- Authors
- Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J.
- Venue
- Nature Reviews Nephrology
- Published
- 2011-05-03
- Volume
- 7
- Issue
- 6
- Pages
- 327-340
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W1996854381
- Cited by
- 1,072
- References
- 133
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.